Please assess the completion status of the following clinical trial:

Trial Title: Treatment of Depression in Parkinson's Disease Trial

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE2
- Number of Arms: 3.0

Eligibility Criteria:
inclusion criteria:~* Parkinson's disease without dementia.~* Depression.~* Males or females.~exclusion criteria:~* Psychosis~* Heart block

- Gender: ALL
- Minimum Age: 35 Years
- Maximum Age: 80 Years
- Healthy Volunteers: f

Study Arms:
- nortriptyline (Type: EXPERIMENTAL): drug
- paroxetine (Type: EXPERIMENTAL): drug
- placebo (Type: PLACEBO_COMPARATOR): placebo

Based on this trial design, predict the completion outcome and termination type (if applicable).